Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Adc Therapeutics Sa (NY: ADCT )

2.550 -0.140 (-5.20%)
Official Closing Price Updated: 7:00 PM EDT, Jun 25, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 611,220
Open 2.680
Bid (Size) 2.280 (41)
Ask (Size) 2.700 (5)
Prev. Close 2.690
Today's Range 2.530 - 2.690
52wk Range 0.3599 - 6.040
Shares Outstanding 76,721,543
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Stocks to Buy: 3 Biotech Bargains Delivering Breakthroughs on a Budget
Since wealth without health is utterly meaningless, investors may have some confidence with these biotech stocks to buy. 
Via InvestorPlace
ADC Therapeutics Makes Grants to New Employees Under Inducement Plan
From ADC Therapeutics SA
Via GlobeNewswire

Performance

YTD
+50.89%
+50.89%
1 Month
-28.57%
-28.57%
3 Month
-41.38%
-41.38%
6 Month
+54.55%
+54.55%
1 Year
+27.50%
+27.50%

More News

Read More
ADC Therapeutics to Participate in the Jefferies Global Healthcare Conference
From ADC Therapeutics SA
Via GlobeNewswire
A Preview Of ADC Therapeutics's Earnings
Via Benzinga
ADC Therapeutics - Time For A Turn-Around?
Via Talk Markets
ADC Therapeutics to Participate in the H.C. Wainwright 2nd Annual BioConnect Investor Conference at NASDAQ
From ADC Therapeutics SA
Via GlobeNewswire
ADC Therapeutics to Participate in 2024 RBC Capital Markets Global Healthcare Conference
From ADC Therapeutics SA
Via GlobeNewswire
ADCT Stock Earnings: ADC Therapeutics Beats EPS, Misses Revenue for Q1 2024
Via InvestorPlace
BioNTech Reports Downbeat Earnings, Joins Medical Properties Trust And Other Big Stocks Moving Lower In Monday's Pre-Market Session
Via Benzinga
ADC Therapeutics Announces $105 Million Underwritten Offering of Common Shares and Pre-Funded Warrants
From ADC Therapeutics SA
Via GlobeNewswire
ADC Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Updates
From ADC Therapeutics SA
Via GlobeNewswire
ADC Therapeutics Announces Initial Data from Investigator-Initiated Phase 2 Clinical Trial of ZYNLONTA® in Patients with Relapsed/Refractory Marginal Zone Lymphoma
From ADC Therapeutics SA
Via GlobeNewswire
ADC Therapeutics Makes Grants to New Employees Under Inducement Plan
From ADC Therapeutics SA
Via GlobeNewswire
ADC Therapeutics to Host First Quarter 2024 Financial Results and Pipeline Update Conference Call on May 6, 2024
From ADC Therapeutics SA
Via GlobeNewswire
Medifast Reports Mixed Results, Joins Coursera, Chegg And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
Via Benzinga
ADC Therapeutics Announces Updates on LOTIS-7 Clinical Trial Evaluating ZYNLONTA® in Combination with Glofitamab or Mosunetuzumab in Patients with Relapsed/Refractory B-cell Non-Hodgkin Lymphoma
From ADC Therapeutics SA
Via GlobeNewswire
ADC Therapeutics to Host a Virtual Research Investor Event on Tuesday, April 9, 2024
From ADC Therapeutics SA
Via GlobeNewswire
ADC Therapeutics Makes Grants to New Employees Under Inducement Plan
From ADC Therapeutics SA
Via GlobeNewswire
Dollar Tree Reports Weak Earnings, Joins Tesla, Arcos Dorados And Other Big Stocks Moving Lower On Wednesday
Via Benzinga
Topics Stocks
Exposures US Equities
ADC Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Updates
From ADC Therapeutics SA
Via GlobeNewswire
ADC Therapeutics to Participate in the Guggenheim 5th Annual Healthy Altitudes Summit
From ADC Therapeutics SA
Via GlobeNewswire
ADC Therapeutics to Host Fourth Quarter and Year-End 2023 Financial Results Conference Call on March 13, 2024
From ADC Therapeutics SA
Via GlobeNewswire
Earnings Scheduled For March 13, 2024
Via Benzinga
ADC Therapeutics Announces Abstracts Accepted for Presentation at the American Association for Cancer Research (AACR) Annual Meeting
From ADC Therapeutics SA
Via GlobeNewswire
ADC Therapeutics to Participate in the TD Cowen 44th Annual Health Care Conference
From ADC Therapeutics SA
Via GlobeNewswire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.